Current Funding Opportunities

Applications focused on research aimed at better understanding and/or addressing the underlying causes, pathophysiology, and brain-related health outcomes of brain cancer may be co-funded by Brain Canada.

All applicants should have demonstrated contributions to research which may or may not have related directly to ALS, but proposed future research and training must be ALS-related. 

Doctoral Scheme 

At the time of application, eligible trainees have applied to, been accepted for, or are within the first three years of a PhD program under the supervision of an investigator who holds an academic position at qualifying Canadian institution, defined according to CIHR guidelines. 

Postdoctoral Scheme 

Qualifying trainees currently hold or have secured a postdoctoral position under the supervision of an investigator who holds an academic position at a qualifying Canadian institution, defined according to CIHR guidelines. At the time of application, applicants should be transitioning from graduate work to a postdoctoral position or be within the first two years of postdoctoral studies. 
 

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.  

This program has been made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada) Brain Canada Foundation, and the ALS Society of Canada. 

This funding is intended to support research projects that are focused and achievable in a short timeframe, yet helpful in guiding future research in Huntington disease.

In order to be eligible for this funding, projects must take place over a 12-week period between May and September, and undergraduate students must be working under the supervision of a Huntington disease researcher with a faculty position.

Send completed applications and any questions to: research@huntingtonsociety.ca

The application form is available at https://www.huntingtonsociety.ca/student-fellowship/

Send Letters of Intent and applications to: research@huntingtonsociety.ca

Questions may be directed to: research@huntingtonsociety.ca

Neurodegenerative diseases are debilitating conditions that lead to the progressive degeneration and death of nerve cells. Their likelihood increases dramatically with age. Worldwide, it is estimated that there are more than 50 million people living with Alzheimer’s disease and related disorders, the most common class of neurodegenerative diseases. This figure is expected to double every 20 years as the population ages. 

The aim of Call 2 is to facilitate multinational, collaborative and interdisciplinary research that addresses critical translational questions. Applications for Call 2 of the EP BrainHealth, should address how biological, social and environmental factors affect the trajectory of neurodegenerative disorders across the lifespan. 

Teams must include at least two researchers (a BC-based primary applicant and a co-lead) and at least one BC-based graduate student, postdoctoral fellow, or early-career researcher.

Teams are encouraged to meaningfully engage with research users, particularly people with lived experience (PWLE; e.g., people living with Parkinson’s or Alzheimer’s and/or their caregivers/care partners), as team members, as appropriate for the project.

Letter of Intent Deadline:  February 2, 2026 at 4:30 p.m. PT
Full Application Deadline (Applicant):  March 26, 2026 at 4:30 p.m. PT
Full Application Deadline (Host Institution): April 2, 2026 at 4:30 p.m. PT

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.

This opportunity is made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the government of Canada (through Health Canada) and Brain Canada Foundation. Together in partnership with the Alzheimer Society of B.C., Branch Out Neurological Foundation, CLEAR Foundation, Health Research BC, Parkinson Society BC, and the Patrick & Dulcie Lenox Endowment, we are advancing meaningful solutions for BC’s aging population and strengthening networks between researchers, partners, and research users.

This program aims to leverage strengths and foster international collaboration between researchers in Canada and the Weizmann Institute of Science in Israel. Its purpose is to support innovative, unorthodox, and exploratory research that may be in the early and conceptual stages of project development but has potential for significant impact on our understanding of the brain and brain disorders.

The research topic will focus on hypothesis-driven inquiries on the brain and nervous system, and may span the range of basic, translational, and clinical approaches, including the study of disease pathogenesis, progression, diagnosis, prevention, and/or treatment.

The Brain Canada & Weizmann Institute of Science Team Grants program has an overall funding envelope of $2,500,000 CAD to support up to five grants of $500,000 CAD each over two years. This funding opportunity is open to research teams of two or more members and must include a minimum of two independent investigators. At least one independent investigator must be conducting research at, and affiliated with, an eligible academic institution in Canada, and one at the Weizmann Institute of Science, designated as co-Principal Investigators.

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.

This program has been made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada) Brain Canada Foundation, and the Weizmann Institute of Science.

Weizmann Canada and Brain Canada gratefully acknowledge the visionary support of Dr. Andreae and other philanthropic partners whose commitment to bold, curiosity-driven research has helped make this renewed program possible.

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.

Should you have any questions, please contact research@heartandstroke.ca

This program has been made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada), Brain Canada Foundation, and Heart & Stroke.

The Cardiac Arrest Team Grants will support multidisciplinary research teams across three key areas:

1. Prediction and early detection: Advancing ability to predict and detect cardiac arrest in the community or in hospital by deepening understanding of its causes and biological mechanisms.
2. Accelerating response and increasing survival: Developing sustainable, evidence-informed approaches to improve emergency response and survival — both out-of-hospital and in-hospital.
3. Optimizing brain recovery: Supporting survivors with evidence-based rehabilitation and recovery strategies that address physical, neurocognitive, and/or mental health needs. This includes support for families, caregivers, and communities.

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.

Click here to view the guidelines.

Registration deadline: December 16, 2025 at 3 p.m. ET

Deadline for receipt of Full Applications: March 17, 2026 at 3 p.m. ET

For more information, or if you have any questions regarding the application process, please consult this FAQ document, or contact research@heartandstroke.ca.

Funding for the Cardiac Arrest Team Grants has been made possible by Heart & Stroke, Canada’s leading health charity devoted to heart disease and stroke, the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada) and Brain Canada Foundation, and Canada’s federal funding agency for health research, the Canadian Institutes of Health Research’s Institute of Circulatory and Respiratory Health.